INS and metabolic dysfunction-associated steatotic liver disease: All of the above evidence suggests that cytokines and chemokines are involved in the development and progression of NAFLD by inducing inflammation, hepatic lipid accumulation, and insulin sensitivity, but whether they could be used as therapeutic or diagnostic targets for NAFLD still needs to be confirmed.